Registration Dossier

Toxicological information

Carcinogenicity

Currently viewing:

Administrative data

Description of key information

According to Annex X, a carcinogenicity study may be required if the substance has a widespread dispersive use or there is evidence of frequent or long-term human exposure and the substance is classified as mutagen category 3 or there is evidence from the repeated dose study(ies) that the substance is able to induce hyperplasia and/or pre-neoplastic lesions. Based on the available data, sodium tungstate is not classified as a mutagen and there is no evidence from repeat dose oral studies on sodium tungstate to indicate that it would induce hyperplasia and/or pre-neoplastic lesions.

Key value for chemical safety assessment

Carcinogenicity: via oral route

Link to relevant study records
Reference
Endpoint:
carcinogenicity
Data waiving:
other justification
Justification for data waiving:
other:
Endpoint conclusion
Endpoint conclusion:
no study available
Quality of whole database:
Data waiver

Carcinogenicity: via inhalation route

Link to relevant study records
Reference
Endpoint:
carcinogenicity
Data waiving:
other justification
Justification for data waiving:
other:
Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via dermal route

Link to relevant study records
Reference
Endpoint:
carcinogenicity
Data waiving:
other justification
Justification for data waiving:
other:
Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

No carcinogenicity data are available for sodium tungstate. Therefore, classification cannot be made due to lack of data.

Additional information

According to Annex X, a carcinogenicity study may be required if the substance has a widespread dispersive use or there is evidence of frequent or long-term human exposure and the substance is classified as mutagen category 3 or there is evidence from the repeated dose study(ies) that the substance is able to induce hyperplasia and/or pre-neoplastic lesions. Based on the available data, sodium tungstate is not classified as a mutagen and there is no evidence from repeat dose oral studies on sodium tungstate to indicate that it would induce hyperplasia and/or pre-neoplastic lesions.